LAVA Therapeutics

+$0.02 (+0.29%) Today
$0.00 (0.00%) As of 8:14 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LVTX and other ETFs, options, and stocks.

About LVTX

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The firm develops next generation T-cell engaging bispecific antibodies to treat cancer.

CEO
Stephen Allen Hurly
Employees
31
Headquarters
Utrecht, Noord-Brabant
Founded
2016

LVTX Key Statistics

Market Cap
177.59M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
101.62K
High Today
$7.37
Low Today
$6.77
Open Price
$6.77
Volume
21.50K
52 Week High
$17.20
52 Week Low
$5.50

LVTX Earnings

-$12.29
-$8.19
-$4.10
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure